Effects of Remimazolam on Neurocognitive Function in Patients Undergoing Cardiovascular Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorChinese Academy of Medical Sciences, Fuwai Hospital

About this trial

The goal of this observational study is to explore the effect of remimazolam-based total intravenous anesthesia on postoperative neurocognitive function in patients who undergo cardiovascular surgery.

The main question this study tries to answer is: Does remimazolam influence the incidence of postoperative delirium in cardiovascular surgery? Participants already apply remimazolam-based total intravenous anesthesia as part of their regular medical treatment for general anesthesia to perform cardiac surgery will answer questionnaires about cognitive function after surgery.

Eligibility criteria

Qualifiers

Male or female adult patients aged 60 years or older

Receiving elective cardiovascular surgery with cardiopulmonary bypass

Written Informed consent provided

Disqualifiers

Deep hypothermia circulatory arrest

Breastfeeding or pregnancy

Mental or legal disability

Terminal illness with a life expectancy of less than 3 months

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

210 Participants
are grouped into 2 trial groups